Evidence map›Paper›PMID 35237951›Full record

ArticleInfection2022

Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19.

Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Leila Rahbarnia, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Fariba Lotfi *Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, P.O. Box 5163639888, Tabriz, Iran.
Mostafa Akbarzadeh-Khiavi *Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Ziba LotfiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Leila RahbarniaInfectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, P.O. Box 5163639888, Tabriz, Iran. le.rahbarnia@gmail.com.ORCID http://orcid.org/0000-0002-4180-8028
Azam SafaryConnective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. safarya@tbzmed.ac.ir.ORCID http://orcid.org/0000-0002-8997-2003
Habib ZarredarTuberculosis and Lung Diseases Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Amir BaghbanzadehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Behrooz NaghiliInfectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, P.O. Box 5163639888, Tabriz, Iran.
Behzad BaradaranImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35237951
PMCPMC8890679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.